ALPHARETTA, Ga. (AP) _ Alimera Sciences Inc. (ALIM) on Monday reported a loss of $3.5 million in its third quarter.
The Alpharetta, Georgia-based company said it had a loss of 39 cents per share. Losses, adjusted for non-recurring gains, were 5 cents per share.
The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 6 cents per share.
The eye drug developer posted revenue of $11.1 million in the period.
The company's shares closed at $1.09. A year ago, they were trading at $1.34.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ALIM at https://www.zacks.com/ap/ALIM